Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-27

Clinical Trial Update: A Safety and Feasibility Study of Re-treating Patients With Severe Emphysema With the RePneu LVRC System. [NA]

View source ↗

Summary

This update covers a completed safety and feasibility study evaluating re-treatment with the RePneu LVRC System in patients with severe emphysema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RePneu LVRC System

Snippet

Sponsor: University Medical Center Groningen | Conditions: COPD, Emphysema | NA | Status: COMPLETED